Results: 54

For: cardiovascular disease

Middle-aged smokers with schizophrenia are significantly more likely to die from cardiac disease

Smoking man

We know from epidemiological studies that people with schizophrenia are 2-3 times more likely to smoke than the rest of the population.  We also know that schizophrenia is associated with a higher risk of coronary heart disease. This retrospective cohort study carried out by researchers from the University of Maryland set out to explore the impact [read the full story…]

Depressed adults who take antidepressants for 12 weeks or more have a reduced incidence of heart attack

shutterstock_3170494 pills in heart shape

This cohort study conducted by researchers from the St. Louis Veterans Affairs Medical Center set out to answer the question: Are antidepressants associated with an increased or decreased risk of incident myocardial infarction and all-cause mortality? 93,653 patients aged 25–80 years (average age 51.5 years, 14.1% female, 77.8% White, 57.1% not married) were identified using the [read the full story…]

People with mental illness are 11% more likely to die after cardiac events than the rest of the population

iStock_000011324210XSmall heart attack

A new meta-analysis published in the British Journal of Psychiatry has found that people with mental health problems are significantly less likely to receive important cardiac treatment (revascularisation, angiography, angioplasty and bypass grafting) following a cardiac event. People with mental illness experience a 14% lower rate of invasive coronary interventions following a cardiac event and [read the full story…]

Should patients with coronary heart disease and depression be given antidepressants?

iStock_000016283608XSmall pills and stethoscope

Patients with coronary heart disease are susceptible to depression and this comorbidity makes cardiovascular outcomes worse. Using antidepressants to treat depression in patients with other health conditions is sometimes quite controversial. This meta-analysis looked at the health effects of selective serotonin reuptake inhibitors (SSRIs) versus placebo or no antidepressants in patients with coronary heart disease [read the full story…]